Abstract
Background
Enterovirus71 (EV71), the major cause of hand, foot, and-mouth disease (HFMD), has increasingly become a public health challenge. Type I interferons (IFNs) can regulate innate and adaptive immune responses to pathogens. MicroRNAs (miRNAs) play regulatory roles in host innate immune responses to viral infections. However, the roles of miR-103 and miR-107 in EV71 infection remain unclear.
Methods
Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to determine the expression of miR-103, miR-107, suppressor of cytokine signaling 3 (SOCS3), VP1, IFN-α, and IFN-β. Virus titers were measured by 50% tissue culture infectious dose (TCID50) assay. Western blot assay was conducted to detect the protein levels of VP1, IFN-α, IFN-β, SOCS3, signal transducer and activator of transcription 3 (STAT3), and phospho-STAT3 (p-STAT3). Immunofluorescence assay was used to detect the protein level of VP1. The concentrations of IFN-α and IFN-β were examined by Enzyme-linked immunosorbent assay (ELISA). The interaction between SOCS3 and miR-103/miR-107 was predicted by starBase and verified by dual-luciferase reporter assay and RNA pull-down assay.
Results
MiR-103 and miR-107 were downregulated and SOCS3 was upregulated in serum from patients with EV71 and EV71-infected cells. Overexpression of miR-103 and miR-107 repressed EV71 replication by inhibiting EV71 titers and VP1 expression. Moreover, upregulation of miR-103 and miR-107 enhanced EV71-triggered the production of type I IFNs. In addition, miR-103 and miR-107 directly targeted SOCS3, and SOCS3 upregulation reversed the effects of miR-103 and miR-107 on EV71 replication and type I IFN response. Importantly, miR-103 and miR-107 increased STAT3 phosphorylation by targeting SOCS3 after EV71 infection.
Conclusion
MiR-103 and miR-107 suppressed EV71 replication and increased the production of type I IFNs by regulating SOCS3/STAT3 pathway, which might provide a novel strategy for developing effective antiviral therapy.
Similar content being viewed by others
Abbreviations
- EV71:
-
Enterovirus71
- HFMD:
-
Hand, foot, and-mouth disease
- IFNs:
-
I interferons
- SOCS3:
-
Suppressor of cytokine signaling 3
- TCID50 :
-
Tissue culture infectious dose
- STAT3:
-
Signal transducer and activator of transcription 3
- p-STAT3:
-
Phospho-STAT3
- ELISA:
-
Enzyme-linked immunosorbent assay
References
Agarwal V, Bell GW, Nam JW, Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. eLife. https://doi.org/10.7554/eLife.05005
Alexander WS (2002) Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2(6):410–416
Ardekani AM, Naeini MM (2010) The role of microRNAs in human diseases. Avicenna J Med Biotechnol 2(4):161
Chang PC, Chen SC, Chen KT (2016) The current status of the disease caused by enterovirus 71 infections: epidemiology, pathogenesis, molecular epidemiology, and vaccine development. Int J Environ Res Public Health 13(9):890
Chea S et al (2015) Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia. Emerg Infect Dis. https://doi.org/10.3201/eid2101.140992
Chen L et al (2016) MicroRNA-223 promotes type I interferon production in antiviral innate immunity by targeting forkhead box protein O3 (FOXO3). J Biol Chem 291(28):14706–14716
Chen HY et al (2019) miR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2. Sci Rep 9(1):9687
Chmiest D et al (2016) Spatiotemporal control of interferon-induced JAK/STAT signalling and gene transcription by the retromer complex. Nat Commun 7:13476
Deng B et al (2016) MicroRNA-103/107 is involved in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells by targeting HIF-1β. Life Sci 147:117–124
Durham GA, Williams JJL, Nasim MT, Palmer TM (2019) Targeting SOCS proteins to control JAK-STAT signalling in disease. Trends Pharmacol Sci 40(5):298–308
Felekkis K, Touvana E, Stefanou C, Deltas C (2010) microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia 14(4):236
Feng N et al (2017) Enterovirus 71-induced has-miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. Virus Res 237:27–36
Forster SC, Tate MD, Hertzog PJ (2015) MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response. Front Immunol 6:334
Gao W, Hou M, Liu X, Li Z, Yang Y, Zhang W (2020) Induction of SOCS expression by EV71 infection promotes EV71 replication. Biomed Res Int 2020:2430640
Ho BC et al (2014) Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun 5:3344
Killip MJ, Fodor E, Randall RE (2015) Influenza virus activation of the interferon system. Virus Res 209:11–22
Koeberlein B et al (2010) Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res 148(1–2):51–59
Liu Y et al (2014) A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes 48(2):260–272
Mahony R, Ahmed S, Diskin C, Stevenson NJ (2016) SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci 73(17):3323–3336
McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15(2):87–103
Miller RC et al (2011) HIV interferes with SOCS-1 and -3 expression levels driving immune activation. Eur J Immunol 41(4):1058–1069
Nguyen NV, Tran JT, Sanchez DJ (2018) HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation. Innate Immun 24(8):490–500
Ong KC, Wong KT (2015) Understanding Enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses. Brain Pathol 25(5):614–624
Pauli EK et al (2008) Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4(11):e1000196
Porritt RA, Hertzog PJ (2015) Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol 36(3):150–160
Raftery N, Stevenson NJ (2017) Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway. Cell Mol Life Sci 74(14):2525–2535
Rasti M, Khanbabaei H, Teimoori A (2019) An update on enterovirus 71 infection and interferon type I response. Rev Med Virol 29(1):e2016
Saguil A, Kane SF, Lauters R, Mercado MG (2019) Hand-foot-and-mouth disease: rapid evidence review. Am Fam Phys 100(7):408–414
Schreiber G, Piehler J (2015) The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol 36(3):139–149
Stanic M (1963) A simplification of the estimation of the 50 percent endpoints according to the Reed and Muench method. Pathol Microbiol (Basel) 26:298–302
Stifter SA, Feng CG (2015) Interfering with immunity: detrimental role of type I IFNs during infection. J Immunol 194(6):2455–2465
Strauss M, Filman DJ, Belnap DM, Cheng N, Noel RT, Hogle JM (2015) Nectin-like interactions between poliovirus and its receptor trigger conformational changes associated with cell entry. J Virol 89(8):4143–4157
Vlotides G et al (2004) SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun 320(3):1007–1014
Wang JX et al (2015) MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD. Circ Res 117(4):352–363
Xu LJ et al (2014) Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS ONE 9(4):e95272
Yang D, Wang X, Gao H, Chen B, Si C, Wang S (2020) Downregulation of miR-155-5p facilitates enterovirus 71 replication through suppression of type I IFN response by targeting FOXO3/IRF7 pathway. Cell Cycle 19(2):179–192
Yu K et al (2017) MicroRNA-548j inhibits type I interferon production by targeting ZBTB11 in patients with chronic hepatitis B. Biochem Biophys Res Commun 488(4):628–633
Yu QF et al (2018) MiR-103/107 induces tumorigenicity in bladder cancer cell by suppressing PTEN. Eur Rev Med Pharmacol Sci 22(24):8616–8623
Zheng Z et al (2013) Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 87(10):5645–5656
Zhu Z, Qi Y, Fan H, Cui L, Shi Z (2016) Systematic identification and bioinformatic analysis of MicroRNAs in response to infections of coxsackievirus A16 and enterovirus 71. Biomed Res Int 2016:4302470
Funding
There is no funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no financial conflict of interest.
Ethical Approval
The design of this protocol follows the tenets of the Declaration of Helsinki, approved by the Ethics Committee of Binhaiwan Central Hospital of Dongguan.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huang, B., Chen, H. & Zheng, Y. MiR-103/miR-107 inhibits enterovirus 71 replication and facilitates type I interferon response by regulating SOCS3/STAT3 pathway. Biotechnol Lett 43, 1357–1369 (2021). https://doi.org/10.1007/s10529-021-03115-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-021-03115-z